Article Versions Notes

Kim E-H, Ko HY, Yu AR, Kim H, Zaheer J, Kang HJ, Lim Y-C, Cho KD, Joo H-Y, Kang MK, et al. Inhibition of HIF-1α by Atorvastatin During ¹³¹I-RTX Therapy in Burkitt’s Lymphoma Model. Cancers. 2020; 12(5):1203. https://doi.org/10.3390/cancers12051203

Kim, Eun-Ho, Hae Young Ko, A Ram Yu, Hyeongi Kim, Javeria Zaheer, Hyun Ji Kang, Young-Cheol Lim, Kyung Deuk Cho, Hyun-Yoo Joo, Min Kyoung Kang, and et al. 2020. "Inhibition of HIF-1α by Atorvastatin During ¹³¹I-RTX Therapy in Burkitt’s Lymphoma Model" Cancers 12, no. 5: 1203. https://doi.org/10.3390/cancers12051203

Kim, E.-H., Ko, H. Y., Yu, A. R., Kim, H., Zaheer, J., Kang, H. J., Lim, Y.-C., Cho, K. D., Joo, H.-Y., Kang, M. K., Lee, J. J., Lee, S.-S., Kang, H. J., Lim, S. M., & Kim, J. S. (2020). Inhibition of HIF-1α by Atorvastatin During ¹³¹I-RTX Therapy in Burkitt’s Lymphoma Model. Cancers, 12(5), 1203. https://doi.org/10.3390/cancers12051203